{"product_id":"resmed-business-model-canvas","title":"ResMed Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResMed Business Model Canvas: Innovation + Recurring Revenue—Download Editable Templates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore ResMed’s Business Model Canvas to see how the company combines medical device innovation, subscription-like software services, and global channel partnerships to capture recurring revenue and scale clinical outcomes.\u003c\/p\u003e\n\u003cp\u003eDownload the full, editable Canvas (Word \u0026amp; Excel) for a section-by-section breakdown—perfect for investors, strategists, and founders who want actionable insights and ready-to-use templates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Healthcare Provider Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eResMed partners with a global network of sleep clinics, hospitals, and specialists who drive diagnosis and prescriptions; these clinical alliances, active across 140 countries, account for roughly 65–70% of ResMed’s device sales in 2025 (company revenue mix). \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInsurance and Government Payers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eResMed partners with private insurers and US government payers (Medicare\/Medicaid) to secure reimbursement for CPAP devices, masks, and remote monitoring; Medicare Part B covers durable medical equipment for sleep apnea, supporting ~40% of US CPAP claims in 2024.\u003c\/p\u003e\n\u003cp\u003eFavorable coverage boosts access among low-income and elderly patients, helping ResMed sustain recurring revenue—device and cloud services drove $4.8B in FY2024 sales, with recurring revenue growth of ~12% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHome Medical Equipment (HME) Distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eResMed depends on a network of ~10,000 DME\/HME providers who fulfill home deliveries and account for roughly 60% of device and consumable revenue; these partners are heavy users of ResMed’s Brightree billing and AirView patient-management platforms, driving recurring SaaS uptake. As of late 2025, supplier ties support scale of the SaaS ecosystem and sustain a steady cadence of replacement masks\/accessories, which represent ~25% of annual consumables sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and Consumer Electronics Leaders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eResMed’s 2025 tie-up with Apple produced the Kontor Head Strap for Apple Vision Pro, blending ResMed facial-interface IP with spatial computing to reach consumer sleep-health users; ResMed reported device-platform collaborations drove a 12% revenue lift in digital services in FY2025 (ended Sept 30, 2025).\u003c\/p\u003e\n\u003cp\u003eThese partnerships feed ResMed Cloud data into Apple Health and other platforms, expanding addressable consumer market beyond clinical OSA (obstructive sleep apnea) patients to an estimated 60M US adults tracking sleep in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2025 Kontor Head Strap co-dev with Apple\u003c\/li\u003e\n\u003cli\u003e12% FY2025 digital services revenue growth\u003c\/li\u003e\n\u003cli\u003eIntegration with Apple Health, Fitbit APIs\u003c\/li\u003e\n\u003cli\u003eAddresses ~60M US consumer sleep trackers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComponent and Logistics Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eResMed’s manufacturing stability hinges on partnerships with semiconductor firms and niche component suppliers; by 2025 ResMed reported inventory days fell to ~58 from 72 in 2022 after supplier diversification for the AirSense 11 rollout.\u003c\/p\u003e\n\u003cp\u003eEfficient global logistics keep gross margins high—logistics optimization cut freight per unit ~12% in 2024, supporting distribution of heavy devices and frequent replacement parts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eInventory days: ~58 (2025)\u003c\/li\u003e\n\u003cli\u003eInventory days: 72 (2022)\u003c\/li\u003e\n\u003cli\u003eFreight cost per unit reduced ~12% (2024)\u003c\/li\u003e\n\u003cli\u003eSupports AirSense 11 global rollout (2023–2025)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResMed drives $4.8B recurring revenue via 140-country network, 10K partners, 65–70% device sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eResMed’s key partners—140-country clinical network, ~10,000 DME\/HME providers, insurers (including Medicare), semiconductor suppliers, and platform deals (Apple, Fitbit)—drive ~65–70% device sales, ~60% device+consumable fulfillment, recurring revenue of $4.8B FY2024 (+12% YoY digital services FY2025), inventory days ~58 (2025), freight\/unit −12% (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical network reach\u003c\/td\u003e\n\u003ctd\u003e140 countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevice sales share\u003c\/td\u003e\n\u003ctd\u003e65–70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDME\/HME partners\u003c\/td\u003e\n\u003ctd\u003e~10,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecurring revenue\u003c\/td\u003e\n\u003ctd\u003e$4.8B FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital services growth\u003c\/td\u003e\n\u003ctd\u003e+12% FY2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory days\u003c\/td\u003e\n\u003ctd\u003e~58 (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFreight\/unit change\u003c\/td\u003e\n\u003ctd\u003e−12% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for ResMed detailing customer segments, channels, value propositions, key activities, resources, partnerships, cost structure and revenue streams, reflecting real-world operations and strategic priorities to support investor presentations, competitive analysis, and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of ResMed’s business model as a pain-point reliever, highlighting how its device-software-service ecosystem streamlines respiratory care, reduces hospital readmissions, and accelerates patient adherence—editable for quick team alignment or board review.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Research and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eR\u0026amp;D drives ResMed’s product pipeline, with the company allocating about 6.4% of 2025 revenue (≈USD 520 million on USD 8.125 billion sales) to new product development, targeting next‑gen cloud‑connected CPAPs, quieter motors, and improved mask comfort.\u003c\/p\u003e\n\u003cp\u003eResMed also scales AI\/ML investments to build predictive sleep‑health algorithms, using tens of millions of anonymized nights of device data to flag risks like atrial fibrillation and COPD exacerbations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Precision Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eResMed runs high-precision plants in Singapore and Australia producing medical-grade CPAPs and masks at scale; in 2025 operational excellence and cost cuts drove gross margins above 60% and reduced manufacturing cost per unit by ~8% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health Software Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eResMed dedicates a large share of R\u0026amp;D and ops to its digital health stack—myAir, AirView—supporting remote monitoring for ~6.5M devices and enabling clinicians to troubleshoot and adjust settings without visits, reducing in-person interventions by an estimated 18% in 2024. In 2025 software dev expanded into Residential Care Software (RCS), integrating Brightree and MEDIFOX DAN to serve ~12,000 out‑of‑hospital providers and add an estimated $150M ARR.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Marketing and Brand Awareness\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eResMed runs large-scale campaigns to raise awareness of sleep apnea and COPD, targeting hundreds of millions undiagnosed people; in 2025 it launched the Tackle Your Sleep campaign as Official Sleep Partner of the British and Irish Lions tour to broaden reach and destigmatize therapy.\u003c\/p\u003e\n\u003cp\u003eThese efforts pair consumer digital screening tools, educational outreach, and marketing to drive earlier diagnosis and uptake of devices and cloud services, supporting ResMed’s 2024 revenue of US$4.9B and recurring SaaS growth.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2025 Tackle Your Sleep: Lions partnership\u003c\/li\u003e\n\u003cli\u003eTargets hundreds of millions undiagnosed\u003c\/li\u003e\n\u003cli\u003eUses digital screening + education\u003c\/li\u003e\n\u003cli\u003eAims to boost device and SaaS adoption\u003c\/li\u003e\n\u003cli\u003eSupports ResMed’s US$4.9B 2024 revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Data Analytics and AI Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eResMed analyzes over 20 billion nights of sleep data to optimize therapy outcomes and deliver provider-ready insights, driving a shift from device sales to recurring digital revenue—digital health and software subscriptions contributed about 28% of FY2025 revenue (~$1.6B of $5.7B reported through Sep 30, 2025).\u003c\/p\u003e\n\u003cp\u003eThe data refines AI coaching in myAir to boost adherence (studies show 10–20% adherence gains), supporting remote patient monitoring and higher lifetime customer value.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e20+ billion nights of data\u003c\/li\u003e\n\u003cli\u003emyAir AI boosts adherence ~10–20%\u003c\/li\u003e\n\u003cli\u003eFY2025 digital revenue ~ $1.6B (28% of $5.7B)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResMed pivots to recurring revenue: $1.6B SaaS, 6.5M cloud devices, AI boosts adherence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eR\u0026amp;D, manufacturing, and digital services drive ResMed’s shift to recurring revenue: FY2025 sales ~$5.7B with digital\/SaaS ~$1.6B (28%); R\u0026amp;D ~6.4% (~$520M); 6.5M devices on cloud; 20B+ nights of data; myAir AI lifts adherence 10–20%; manufacturing cost\/unit down ~8%; campaigns target hundreds of millions undiagnosed.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$5.7B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\/SaaS\u003c\/td\u003e\n\u003ctd\u003e$1.6B (28%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e$520M (6.4%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevices cloud\u003c\/td\u003e\n\u003ctd\u003e6.5M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eData nights\u003c\/td\u003e\n\u003ctd\u003e20B+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Document Unlocks After Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the authentic ResMed Business Model Canvas—not a mockup or sample—and reflects the exact structure and content you’ll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eOn completion of your order you’ll get this same professional, ready-to-edit file, formatted consistently and delivered in both Word and Excel for immediate use.\u003c\/p\u003e\n\u003cp\u003eNo placeholders or hidden sections—what you see here is the real deliverable, ready for presentation and customization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749067764089,"sku":"resmed-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/resmed-business-model-canvas.png?v=1772212819","url":"https:\/\/growthsharematrix.com\/products\/resmed-business-model-canvas","provider":"Growth Share Matrix","version":"1.0","type":"link"}